Skip to Main Content
Contact Us
Enhancing the Data Journey in Oncology Clinical Trials Clinical trials are the springboard for progress in modern healthcare, guiding the development and evaluation Read Now Highlights of ESMO 2023: The year of ADCs Insights from the annual oncology conference By Andrew Zupnick, PhD, Vice President of Oncology Drug Read Now Catalyst Clinical Research Honored for Innovative Use of AI Catalyst Accepts Award for Our Support of Drug Development Recognition from Medidata for support of Read Now Catalyst Clinical Research Named One of Fastest Growing Companies Catalyst Ranks in Top of Annual List For fourth consecutive year, CRO recognized for its Read Now Medidata Announces Multi-Year Partnership Expansion with Catalyst for Oncology Trial Delivery Expanded Collaboration Continues to Deliver for CRO and Its Clients Ongoing collaboration demonstrates Medidata’s expertise Read Now Helping to Bring Immunotherapies to Cancer Patients in Need Catalyst Oncology is a specialty oncology clinical research organization (CRO) devoting time, energy, and capital Read Now Agile Protocol Development Medical Writing Services Help Achieve Client’s Goal Pharmaceutical companies are increasingly seeking new avenues to Read Now Rapid Report on Rare Disease Epidemiology Medical Writing and RWE Expert Staff Increased Operational Efficiency Diversity in clinical trials has gained Read Now Providing Support to Succeed Catalyst Flex Delivers Clinical Monitoring Oversight Experts on Phase III Global Study Situation A small Read Now Catalyst Clinical Research Earns Spot on Inc. 5000 List of Fastest-Growing Private Companies CRO Ranks in Top Half of Annual List Revenue increase and bump in employee headcount Read Now